Stocks and Investing Stocks and Investing
Fri, July 28, 2023

David Nierengarten Maintained (TSVT) at Buy with Decreased Target to $22 on, Jul 28th, 2023


Published on 2024-10-28 05:13:06 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $26 to $22 on, Jul 28th, 2023.

David, nor any peers, have made any analyst calls on TSVT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources